Hydroxyethylpiperazine Ethane Sulfonic Acid (HEPES)

Functions
Exfoliator
Skin whitening agent
Sebum regulator
Anti-acne
Buffering
CAS Number(s)
7365-45-9
EINECS number(s)
230-907-9
FDA UNII
RWW266YE9I
INCI name
Hydroxyethylpiperazine Ethane Sulfonic Acid

Hydroxyethylpiperazine Ethane Sulfonic Acid (HEPES, also known under the trade name PromaCare-HEPES) is an organosulfur acid with an AHA-like structure and action. Although it is not a classic hydroxy acid, thanks to structural similarities and faintly acidic properties, it also acts as an exfoliating agent like AHAs and BHAs, breaking bonds between keratinocytes, softening keratin, and eliminating old, dull, and dead cells from the skin surface.

Gently removing pigmented cells (keratinocytes containing melanin) from the epidermal layer, Hydroxyethylpiperazine Ethane Sulfonic Acid leaves a significant skin-whitening effect, while smoothing the surface, softening texture, and unifying the tone. In addition, it enhances the adsorption of other active ingredients and acts as a buffering agent, maintaining the formula's pH over an extended period.

Thanks to stabilizing properties, Hydroxyethylpiperazine Ethane Sulfonic Acid protects active ingredients and skin from UV and visible light exposure, adsorbing and partially reflecting harmful radiation. It has good membrane impermeability and practically doesn't penetrate through the epidermis, and has a very narrow action on biochemical processes in the deeper layers of the skin.

When combined with Salicylic acid (BHA), Glycolic and Citric acids (AHAs), HEPES showed promising results in the treatment of acne. Moreover, a similar blend was clinically tested for the treatment of acne-induced post-inflammatory hyperchromia and sebum control, showing a notable reduction of skin oiliness and hyperchromic lesions.

HEPES has good solubility in water, heat resistance, membrane impermeability, and greater stability against oxidation-reduction reactions and UV exposure, making it a good candidate for exfoliating, sun-care, and skin-lightening formulations.

Changed

References

Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris
Author(s):
, , , ,
PMID:
23545907
Clinical evaluation of the efficacy of a facial serum containing dioic acid, glycolic acid, salicylic acid, LHA, citric acid, and HEPES in treating post-inflammatory hyperchromia and controlling oily skin in patients with acne vulgaris
Author(s):
, , , , ,
PMID:
33617668
DOI:
10.1111/jocd.14016